Azacitidine Glenmark 25 mg/ml Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

azacitidine glenmark 25 mg/ml

glenmark pharmaceuticals s.r.o., Česká republika - azacitidín - 44 - cytostatica

Inaqovi Європейський Союз - словацька - EMA (European Medicines Agency)

inaqovi

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukémia, myeloid - antineoplastické činidlá - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.